Recent studies suggest GLP-1 obesity treatments may reduce cancer risk, showing correlation with decreased incidence in 6 out of 7 cancers, potentially through anti-inflammatory effects beyond weight loss.
Osaka Prefectural Police have referred a 35-year-old company employee and two others to prosecutors on suspicion of violating the Pharmaceuticals and Medical Devices Act by illegally selling and storing the diabetes drug Mounjaro without a license. The drug, known for its appetite-suppressing effects and marketed as a "slimming drug" on social media, has seen widespread use for diet purposes.
Osaka Prefectural Police have referred three individuals (ages 22-35) from Osaka and Nara prefectures to prosecutors on suspicion of violating the Pharmaceuticals and Medical Devices Act by illegally selling the diabetes drug Mounjaro on social media. The drug is increasingly used by young people for weight loss, leading to concerns about online private sales.
Osaka Prefectural Police have referred three individuals, aged 22-35, to prosecutors for allegedly selling Eli Lilly's diabetes drug 'Mounjaro' without authorization, often marketed as a weight-loss aid on social media. This marks the first such case for the Osaka police and is rare nationwide.
Osaka police have referred three individuals (ages 22-35) from Osaka and Nara prefectures to prosecutors on suspicion of violating the Pharmaceuticals and Medical Devices Act for illegally selling the diabetes drug Mounjaro online, reportedly for diet purposes. This marks a rare nationwide case of prosecution for the personal online sale of Mounjaro, which is gaining popularity among young people for weight loss.
